NL8201413A - Farmaceutische preparaten voor plaatselijke toepassing en werkwijzen voor het bereiden en toepassen van deze preparaten. - Google Patents

Farmaceutische preparaten voor plaatselijke toepassing en werkwijzen voor het bereiden en toepassen van deze preparaten. Download PDF

Info

Publication number
NL8201413A
NL8201413A NL8201413A NL8201413A NL8201413A NL 8201413 A NL8201413 A NL 8201413A NL 8201413 A NL8201413 A NL 8201413A NL 8201413 A NL8201413 A NL 8201413A NL 8201413 A NL8201413 A NL 8201413A
Authority
NL
Netherlands
Prior art keywords
skin
compatible
active agent
ester
composition according
Prior art date
Application number
NL8201413A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH2327/81A external-priority patent/CH653256A5/de
Priority claimed from CH2631/81A external-priority patent/CH647149A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8201413A publication Critical patent/NL8201413A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8201413A 1981-04-06 1982-04-02 Farmaceutische preparaten voor plaatselijke toepassing en werkwijzen voor het bereiden en toepassen van deze preparaten. NL8201413A (nl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CH2327/81A CH653256A5 (en) 1981-04-06 1981-04-06 Microemulsion for cutaneous use
CH232781 1981-04-06
CH2631/81A CH647149A5 (en) 1981-04-22 1981-04-22 Composition with 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole for cutaneous use
CH263181 1981-04-22
CH327881 1981-05-20
CH327881 1981-05-20

Publications (1)

Publication Number Publication Date
NL8201413A true NL8201413A (nl) 1982-11-01

Family

ID=27173625

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8201413A NL8201413A (nl) 1981-04-06 1982-04-02 Farmaceutische preparaten voor plaatselijke toepassing en werkwijzen voor het bereiden en toepassen van deze preparaten.

Country Status (16)

Country Link
AU (1) AU564570B2 (fr)
CA (1) CA1192496A (fr)
DE (1) DE3212053A1 (fr)
DK (1) DK155882A (fr)
ES (1) ES8308698A1 (fr)
FI (1) FI821123A7 (fr)
FR (1) FR2502951B1 (fr)
GB (2) GB2098865B (fr)
GR (1) GR75462B (fr)
IL (1) IL65424A0 (fr)
IT (1) IT8220611A0 (fr)
MY (1) MY8600571A (fr)
NL (1) NL8201413A (fr)
NZ (1) NZ200232A (fr)
PT (1) PT74703B (fr)
SE (1) SE8202172L (fr)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655656B (fr) * 1982-10-07 1986-05-15
CA1225594A (fr) * 1983-05-20 1987-08-18 Jourge Heller Methode pour l'administration percutanee d'agents actifs
DE3406497A1 (de) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
JPH0667835B2 (ja) * 1984-03-01 1994-08-31 サンド・アクチエンゲゼルシヤフト 医薬組成物
US5364628A (en) * 1985-05-31 1994-11-15 Sandoz Ltd. Pharmaceutical compositions
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
JPS61280426A (ja) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
US4767625A (en) * 1985-09-02 1988-08-30 Kao Corporation Lamella type single phase liquid crystal composition and oil-base cosmetic compositions using the same
US4690774A (en) 1985-09-11 1987-09-01 Chesebrough Pond's Inc. Novel translucent water in oil emulsions
US4797272A (en) * 1985-11-15 1989-01-10 Eli Lilly And Company Water-in-oil microemulsions for cosmetic uses
DE3805744C2 (de) * 1987-03-04 1999-09-23 Novartis Ag Phenylcarbamate zur Hemmung der Acetylcholinesterase
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
DE3908047A1 (de) * 1989-03-13 1990-09-20 Desitin Arzneimittel Gmbh Hochdisperse pharmazeutische zusammensetzung
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
US5149719A (en) * 1990-04-27 1992-09-22 Minnesota Mining And Manufacturing Company Composition for transdermal penetration of medicaments
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
DE69229779T2 (de) * 1991-04-19 1999-12-23 Lds Technologies, Inc. Konvertierbare mikroemulsionsverbindungen
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
GB9111611D0 (en) 1991-05-30 1991-07-24 Sandoz Ltd Liposomes
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
GB9126209D0 (en) * 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
WO1993011798A1 (fr) * 1991-12-16 1993-06-24 Alza Corporation Formulations ameliorees avec agent d'amelioration de la penetration hydrophobe
US5629019A (en) * 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
SG45449A1 (en) 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
DK0589843T3 (da) 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
JPH08505367A (ja) * 1992-10-16 1996-06-11 スミスクライン・ビーチャム・コーポレイション 医薬用エマルジョン組成物
JPH08507065A (ja) * 1993-02-17 1996-07-30 スミスクライン・ビーチャム・コーポレイション 医薬組成物含有のミクロエマルジョン
ATE218359T1 (de) 1994-11-03 2002-06-15 Novartis Erfind Verwalt Gmbh Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
DE4442999A1 (de) 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
PT988046E (pt) 1997-01-30 2004-12-31 Novartis Ag Composicoes farmaceuticas sem oleo contendo ciclosporina a
IN188719B (fr) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
US6391282B1 (en) * 1997-11-10 2002-05-21 Flemington Pharmaceutical Corp. Antihistamine sprays and ointments for relief of delayed contact dermatitis
DE19825856A1 (de) * 1998-06-10 1999-12-16 Labtec Gmbh Topische Arzneimittelzubereitung
KR100602725B1 (ko) 1998-12-11 2006-07-20 파마솔루션스, 인코포레이티드 물에서 불충분하게 용해되는 약제를 위한 자가-유화용조성물
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
EP1644004A4 (fr) * 2003-06-20 2010-10-06 Ronald Aung-Din Therapie locale pour le traitement des migraines, des claquages musculaires, des spasmes musculaires, de la spasticite et d'etats apparentes
JP2007513199A (ja) 2003-12-08 2007-05-24 ベントレー ファーマスーティカルス，インコーポレイテッド インスリン治療のための薬学的組成物及び方法
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US7740875B2 (en) 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US9308203B2 (en) * 2008-10-01 2016-04-12 Taiwan Biotech Co., Ltd. Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016033549A2 (fr) 2014-08-28 2016-03-03 Lipocine Inc. Compositions de (17-ss)-3-oxoandrost-4-èn-17-yl tridécanoate et leurs procédés de préparation et d'utilisation
WO2016205423A2 (fr) 2015-06-15 2016-12-22 Lipocine Inc. Composition et méthode pour l'administration orale de promédicaments androgènes
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (fr) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Compositions d'hormones stéroïdes dans des huiles à chaîne moyenne
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
CA3078723A1 (fr) 2016-11-28 2018-05-31 Nachiappan Chidambaram Traitement oral a base d'undecanoate de testosterone
EP3824296B1 (fr) 2018-07-20 2026-04-01 Lipocine Inc. Composition pharmaceutique orale comprenant du tridécanoate de testostérone et/ou du dodécanoate de testostérone pour le traitement des maladies du foie

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH570401A5 (fr) * 1972-05-09 1975-12-15 Wander Ag Dr A
GB1559811A (en) * 1975-07-28 1980-01-30 Sandoz Ltd Pharmaceutically active benzothiadiazole derivatives
CH632268A5 (de) * 1977-01-14 1982-09-30 Sandoz Ag Verfahren zur herstellung von neuen heterocyclylaminoderivaten.

Also Published As

Publication number Publication date
GB2098865A (en) 1982-12-01
IL65424A0 (en) 1982-07-30
CA1192496A (fr) 1985-08-27
FI821123L (fi) 1982-10-07
FR2502951B1 (fr) 1985-12-06
DE3212053A1 (de) 1982-10-21
PT74703B (en) 1984-05-30
GB2148711A (en) 1985-06-05
MY8600571A (en) 1986-12-31
ES511169A0 (es) 1983-10-01
FR2502951A1 (fr) 1982-10-08
PT74703A (en) 1982-05-01
GB8408654D0 (en) 1984-05-16
AU564570B2 (en) 1987-08-20
GB2098865B (en) 1985-12-18
GR75462B (fr) 1984-07-20
ES8308698A1 (es) 1983-10-01
GB2148711B (en) 1985-12-18
IT8220611A0 (it) 1982-04-06
DK155882A (da) 1982-12-10
NZ200232A (en) 1985-08-16
FI821123A0 (fi) 1982-03-31
FI821123A7 (fi) 1982-10-07
AU8233482A (en) 1982-10-14
SE8202172L (sv) 1982-10-07

Similar Documents

Publication Publication Date Title
CA1192496A (fr) Composes pharmaceutiques a usage topique
CA1228812A (fr) Fabrication de produits pharmaceutiques inedits pour usage topique
JP6105475B2 (ja) 可溶性の乏しい化合物の可溶性を増大させる方法ならびにそのような化合物の配合物を作る、および用いる方法
ES2565317T3 (es) Composición tópica para el cuidado de la piel
RU2560677C2 (ru) Кожная композиция, включающая аналог витамина d и смесь растворителя и поверхностно-активных веществ
US20130202650A1 (en) Topical composition comprising a combination of at least two penetration enhancing agents
EP0044543B1 (fr) Formulations topiques à base de 9(2-hydroxyéthoxyméthyl) guanine
JPH01193206A (ja) 皮膚の老化に対するアデメチオニンの用途
JPH0148885B2 (fr)
BR112021003877A2 (pt) composições farmacêuticas à base de óleo semissólidas que contêm pirfenidona para aplicação em reparo tecidual
WO2000001390A1 (fr) Formulations topiques d'aciclovir
JP2001181180A (ja) 油中水型乳化組成物
JP2003183117A (ja) 経皮吸収促進剤及びこれを含有する皮膚外用剤
AU643975B2 (en) Pharmaceutical formulation
JP3313891B2 (ja) 経皮吸収促進剤及び皮膚外用剤
EP0593562B1 (fr) Composition topique contenant du penciclovir
JPH0735330B2 (ja) 外用クリ−ム組成物
JP4463621B2 (ja) 抗炎症作用を有する皮膚外用剤
JPH05331050A (ja) 消炎鎮痛外用剤
IE902819A1 (en) Pharmaceutical formulation
US11007161B1 (en) Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
JPH0772133B2 (ja) 安定なケトプロフエン含有クリ−ム製剤
JPH05331049A (ja) 消炎鎮痛外用剤
FR2572933A1 (fr) Compositions pharmaceutiques topiques a base de tizanidine
JPH0232019A (ja) 外用剤

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BT A notification was added to the application dossier and made available to the public
BV The patent application has lapsed